Article Text

PDF

Combined use of 99mtechnetium-labelled macroaggregates of albumin and 75selenium-selenomethionine in the diagnosis of lung cancer
  1. Mair Critchley,
  2. H. J. Testa,
  3. T. B. Stretton
  1. Departments of Medical Physics and Medicine, Manchester Royal Infirmary

    Abstract

    Critchley, M., Testa, H. J., and Stretton, T. B. (1974).Thorax, 29, 421-424. Combined use of 99mtechnetium-labelled macroaggregates of albumin and 75selenium-selenomethionine in the diagnosis of lung cancer. A two-stage isotope technique has been used in 30 patients with radiographic evidence of circumscribed pulmonary lesions in an attempt to establish the nature of the underlying pathological process. The test was carried out as a `blind' procedure without knowledge of the findings of investigations other than the plain chest radiograph. An initial scan was performed with 99mtechnetium-labelled macroaggregated albumin. The view showing the lesion most clearly was selected and a second scan was obtained after an intravenous injection of 75Se-selenomethionine. Scans were interpreted by comparison of the `cold area' on the technetium scan with the corresponding area on the selenomethionine scan. Accumulation of 75Se-selenomethionine at the site corresponding to the lesion is described as a positive result and absence of accumulation as negative. The findings suggest that there is selective uptake of 75Se-selenomethionine by primary bronchogenic carcinoma; in the few patients with secondary carcinomas and non-malignant disease investigated so far, the lesion has failed to concentrate 75Se-selenomethionine.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.